Increased arginine vasopressin mRNA expression in the human hypothalamus in depression: A preliminary report

被引:77
作者
Meynen, Gerben
Unmehopa, Unga A.
van Heerikhuize, Joop J.
Hofman, Michel A.
Swaab, Dick F.
Hoogendijk, Witte J. G.
机构
[1] VU Univ Med Ctr, Dept Psychiat, GGZ Buitenamstel, NL-1075 BG Amsterdam, Netherlands
[2] Netherlands Inst Brain Res, Amsterdam, Netherlands
关键词
depression; melancholic type; vasopressin; hypothalamus; postmortem; hypothalamic-pituitary-adrenal axis; CORTICOTROPIN-RELEASING HORMONE; IN-SITU HYBRIDIZATION; PARAVENTRICULAR NUCLEUS; CORTICOSTEROID RECEPTORS; NEURONS; RAT; PLASMA; SECRETION; OXYTOCIN; STRESS;
D O I
10.1016/j.biopsych.2005.12.010
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Background: Elevated arginine vasopressin (AVP) plasma levels have been observed in major depression, particularly in relation to the melancholic subtype. Two hypothalamic structures produce plasma vasopressin: the supraoptic nucleus (SON) and the paraventricular nucleus (PVN). The aim of this study was to establish which structure is responsible for the increased vasopressin plasma levels in depression. Methods: Using in situ hybridization, we determined the amount of vasopressin messenger ribonucleic acid (mRNA) in the PVN and SON in postmortem brain tissue of nine depressed subjects (six with the melancholic subtype) and eight control subjects. Results: In the SON a 60% increase of vasopressin mRNA expression was found in depressed compared with control subjects. In the melancholic subgroup, AVP mRNA expression was significantly increased in both the SON and the PVN compared with control subjects. Conclusions. We found increased AVP gene expression in the SON in depressed subjects. This might partly explain the observed increased vasopressin levels in depression.
引用
收藏
页码:892 / 895
页数:4
相关论文
共 25 条
[1]   VASOPRESSINERGIC CONTROL OF PITUITARY ADRENOCORTICOTROPIN SECRETION COMES OF AGE [J].
ANTONI, FA .
FRONTIERS IN NEUROENDOCRINOLOGY, 1993, 14 (02) :76-122
[2]   Vasopressin in CSF and plasma in depressed suicide attempters: preliminary results [J].
Brunner, J ;
Keck, ME ;
Landgraf, R ;
Uhr, M ;
Namendorf, C ;
Bronisch, T .
EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2002, 12 (05) :489-494
[3]   Anxious-retarded depression: Relation with plasma vasopressin and cortisol [J].
de Winter, RFP ;
van Hemert, AM ;
DeRijk, RH ;
Zwinderman, KH ;
Frankhuijzen-Sierevogel, AC ;
Wiegant, VM ;
Goekoop, JG .
NEUROPSYCHOPHARMACOLOGY, 2003, 28 (01) :140-147
[4]   Glucocorticoids suppress corticotropin-releasing hormone and vasopressin expression in human hypothalamic neurons [J].
Erkut, ZA ;
Pool, C ;
Swaab, DF .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1998, 83 (06) :2066-2073
[5]   STIMULATION OF THE PITUITARY-ADRENAL AXIS WITH A LOW-DOSE [ARG8]-VASOPRESSIN IN DEPRESSED-PATIENTS AND HEALTHY-SUBJECTS [J].
GISPENDEWIED, CC ;
WESTENBERG, HGM ;
KOPPESCHAAR, HPF ;
THIJSSEN, JHH ;
VANREE, JM .
EUROPEAN NEUROPSYCHOPHARMACOLOGY, 1992, 2 (04) :411-419
[6]   Loss of vasopressin-immunoreactive neurons in alcoholics is dose-related and time-dependent [J].
Harding, AJ ;
Halliday, GM ;
Ng, JLF ;
Harper, CG ;
Kril, JJ .
NEUROSCIENCE, 1996, 72 (03) :699-708
[7]   Stress, hypercortisolism and corticosteroid receptors in depression: implicatons for therapy [J].
Holsboer, F .
JOURNAL OF AFFECTIVE DISORDERS, 2001, 62 (1-2) :77-91
[8]   Arginine vasopressin is associated with hypercortisolemia and suicide attempts in depression [J].
Inder, WJ ;
Donald, RA ;
Prickett, TCR ;
Frampton, CM ;
Sullivan, PF ;
Mulder, RT ;
Joyce, PR .
BIOLOGICAL PSYCHIATRY, 1997, 42 (08) :744-747
[9]   Reduction of hypothalamic vasopressinergic hyperdrive contributes to clinically relevant behavioral and neuroendocrine effects of chronic paroxetine treatment in a psychopathological rat model [J].
Keck, ME ;
Welt, T ;
Müller, MB ;
Uhr, M ;
Ohl, F ;
Wigger, A ;
Toschi, N ;
Holsboer, F ;
Landgraf, R .
NEUROPSYCHOPHARMACOLOGY, 2003, 28 (02) :235-243
[10]   Role of glucocorticoid hormones in arginine vasopressin gene regulation [J].
Kim, JK ;
Summer, SN ;
Wood, WM ;
Schrier, RW .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2001, 289 (05) :1252-1256